These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 10354385

  • 1. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
    Mody M, Lazarus AH, Semple JW, Freedman J.
    Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy.
    Ahnadi CE, Sabrinah Chapman E, Lépine M, Okrongly D, Pujol-Moix N, Hernández A, Boughrassa F, Grant AM.
    Thromb Haemost; 2003 Nov; 90(5):940-8. PubMed ID: 14597991
    [Abstract] [Full Text] [Related]

  • 4. [Platelet activation in cardiology: methods, indications and therapeutic perspectives].
    Hézard N, Metz D, Simon G, Droullé C, Daliphard S, Potron G.
    J Mal Vasc; 1999 Oct; 24(4):288-93. PubMed ID: 10582178
    [Abstract] [Full Text] [Related]

  • 5. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
    Macey M, McCarthy D, Azam U, Milne T, Golledge P, Newland A.
    Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.
    Macey M, Azam U, McCarthy D, Webb L, Chapman ES, Okrongly D, Zelmanovic D, Newland A.
    Clin Chem; 2002 Jun; 48(6 Pt 1):891-9. PubMed ID: 12029005
    [Abstract] [Full Text] [Related]

  • 7. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations.
    Kim HK, Song KS, Lee ES, Lee YJ, Park YS, Lee KR, Lee SN.
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):393-7. PubMed ID: 12138366
    [Abstract] [Full Text] [Related]

  • 8. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.
    Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, Boer K, Sturk A.
    Am J Obstet Gynecol; 1997 Aug; 177(2):434-42. PubMed ID: 9290465
    [Abstract] [Full Text] [Related]

  • 9. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin.
    Lozano ML, Rivera J, Gónzález-Conejero R, Moraleda JM, Vicente V.
    Transfusion; 1997 Apr; 37(4):368-75. PubMed ID: 9111273
    [Abstract] [Full Text] [Related]

  • 10. [Impact of shear stress on expression of platelet membrane glycoproteins].
    Li M, Cong Y, Deng X, Hu J, Qin X.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):267-70. PubMed ID: 11953177
    [Abstract] [Full Text] [Related]

  • 11. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies.
    Hagberg IA, Lyberg T.
    Platelets; 2000 May 25; 11(3):137-50. PubMed ID: 10938890
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
    Ozsavci D, Yardimci T, Demirel GY, Demiralp E, Uras F, Onder E.
    Platelets; 2002 Jun 25; 13(4):223-9. PubMed ID: 12189024
    [Abstract] [Full Text] [Related]

  • 13. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model.
    Gutensohn K, Beythien C, Bau J, Meinertz T, Kuehnl P.
    Thromb Res; 1997 Apr 01; 86(1):49-56. PubMed ID: 9172286
    [Abstract] [Full Text] [Related]

  • 14. [The study of anticoagulants selection in platelet-rich plasma preparation].
    Hua L, Lai G, Zhenjun L, Guie M.
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul 01; 31(4):295-300. PubMed ID: 26665933
    [Abstract] [Full Text] [Related]

  • 15. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
    McKenzie ME, Malinin AI, Bell CR, Dzhanashvili A, Horowitz ED, Oshrine BR, Atar D, Serebruany VL.
    Blood Coagul Fibrinolysis; 2003 Apr 01; 14(3):249-53. PubMed ID: 12695747
    [Abstract] [Full Text] [Related]

  • 16. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ, Taatjes DJ, Sobel BE.
    Cardiovasc Res; 2000 Jan 14; 45(2):437-46. PubMed ID: 10728364
    [Abstract] [Full Text] [Related]

  • 17. Impact of buffy coat storage on the generation of inflammatory cytokines and platelet activation.
    Klüter H, Schlenke P, Müller-Steinhardt M, Paulsen M, Kirchner H.
    Transfusion; 1997 Apr 14; 37(4):362-7. PubMed ID: 9111272
    [Abstract] [Full Text] [Related]

  • 18. Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro.
    Inoue T, Sohma R, Morooka S.
    Thromb Res; 1999 Feb 01; 93(3):137-43. PubMed ID: 10030830
    [Abstract] [Full Text] [Related]

  • 19. Redistribution of membrane glycoproteins in platelets activated under flow conditions.
    Lozano M, Escolar G, White JG, Tàssies D, Ordinas A, Díaz-Ricart M.
    Blood Coagul Fibrinolysis; 1996 Mar 01; 7(2):214-7. PubMed ID: 8735822
    [Abstract] [Full Text] [Related]

  • 20. Paraformaldehyde fixation induces a systematic activation of platelets.
    Schmidt V, Hilberg T, Franke G, Gläser D, Gabriel HH.
    Platelets; 2003 Aug 01; 14(5):287-94. PubMed ID: 12944245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.